medline.ch Onkologie Haut

	Regulatable membrane-bound IL-15 engineered TIL cell therapy for immune checkpoint inhibitor-resistant advanced melanoma: pooled analysis of phase 1 and 1/2 trials. Nat Med Amaria RN, Chesney JA, Betof AS, In GK, Shoushtari AN, Johnson TT, Hamid O, Samhouri Y, Davies MA, Tawbi HA, Glitza Oliva IC, Aksoy BA, Kelly AM, Duan R, Prabhakar P, Ramsingh G, Jagasia M, Hari P. PMID: 42977756 [PubMed - as supplied by publisher]
	Acral melanoma: a unique subtype requiring unique solutions. Trends Cancer Possik PA, Robles-Espinoza CD, Adams DJ, Rebecca VW, Yeh I, Robertson GP, Couts KL, Smalley KSM, Judson-Torres RL, Aplin AE, Neumann NM, Semenov YR, In GK, Levy J, Hurlbert MS, Acral Melanoma Research Consortium, Bastian B, White R, Villanueva J. PMID: 42977670 [PubMed - as supplied by publisher]
	[Cervical lymph node metastasis as the initial presentation of poorly differentiated esophageal carcinoma mimicking breast origin: a diagnostic challenge]. Rev Gastroenterol Peru Ayala Antonio MJ, Velita Miranda NK, Huiza Centeno XL, Torres-Salinas C. PMID: 42977284 [PubMed - indexed for MEDLINE]
	Evaluating the Clinical Efficacy, Utility, and Role of the 40-Gene Expression Profiling Test in Assessing Prognosis of Cutaneous Squamous Cell Carcinoma: An Expert Consensus Panel. J Drugs Dermatol Burshtein J, Rosenberg A, Arron ST, Bartley B, Cotter D, Desai SR, DeBusk L, Farberg A, Nguyen HP, Schlesinger T, Shah M, Zakria D, Zeitouni N, Rigel D. PMID: 42976841 [PubMed - indexed for MEDLINE]
	Immunosuppressive and Immunomodulatory Dermatologic Therapies: Cancer Risk for Patients With Active or Prior Malignancy. J Drugs Dermatol Khuhro A, Kaufman L, Kobayashi S. PMID: 42976837 [PubMed - indexed for MEDLINE]
	Increased Risk of Skin Cancers in Certain Occupations. J Drugs Dermatol Meledathu S, Noda I, Mitre M, Ashinoff R. PMID: 42976832 [PubMed - indexed for MEDLINE]
	Can Esophagectomy be Safely Avoided After Clinical Complete Response in Esophageal Squamous Cell Carcinoma? Response Assessment, Active Surveillance, and Salvage in the Immunotherapy Era. Curr Oncol Rep Sagawa T, Hirakawa M, Nagashima H, Fujikawa K. PMID: 42975733 [PubMed - indexed for MEDLINE]
	A Review of the Use of Ex-Vivo Confocal Microscopy in the Management of Non-Melanoma Skin Cancers. Dermatol Surg Alladeen A, Vijayvargiya N, Anumolu A, Mahadeo S, Minkis K. PMID: 42975558 [PubMed - as supplied by publisher]
	Leptomeningeal carcinomatosis arising from esophageal cancer: a systematic review of the literature. Dis Esophagus Mylonakis A, Stylios D, Tsilimigras D, Charalampopoulos G, Kotsantis I, Liontos M, Georgakopoulos I, Schizas D. PMID: 42974869 [PubMed - indexed for MEDLINE]
	Exploring the potential role of PD-L2 in primary melanoma immunotherapy resistance: a hypothesis-driven dual-ligand framework. Front Immunol Song W, Tao Y, Ji X, Fu W, Cai X, Shan X. PMID: 42974102 [PubMed - indexed for MEDLINE]
	Efficacy and safety analysis of consolidation immunotherapy following definitive concurrent chemoradiotherapy for locally advanced esophageal squamous cell carcinoma. Front Immunol Liu W, Zhu Q, Xu S, Chen J, Wang D, Wu T, Shen J, Zhu Y, Chen Z, Liu Y, Wang G, Wu C, Wang Y. PMID: 42973545 [PubMed - indexed for MEDLINE]
	The gut microbiome in immunotherapy - lessons learned from melanoma and implications for gastrointestinal tumors. Best Pract Res Clin Gastroenterol Westphal JR, Macke L, Graf C, Schulz C. PMID: 42971667 [PubMed - indexed for MEDLINE]
	Pre-treatment machine learning prediction of local failure and time to local failure after Gamma Knife radiosurgery for radioresistant brain metastases. J Neurooncol Reyes JS, Shohayeb MAM, Bouras A, Lunsford LD, Hadjipanayis CG, Niranjan A. PMID: 42970176 [PubMed - indexed for MEDLINE]
	B cells and the therapeutic index of checkpoint blockade. J Clin Invest Li CY. PMID: 42969237 [PubMed - indexed for MEDLINE]
	Treatment patterns and characteristics of Chinese patients with advanced or resectable melanoma: a multicenter retrospective study. Future Oncol Jiang Y, Gu J, Chen Y, Zhang X, Qiu Y, Liu J, Lin J, Sheng X, Fan H, Li H, Jin X, Tang W, Guo J, Fang M, Si L. PMID: 42968552 [PubMed - as supplied by publisher]
	Evaluation of the efficacy and safety of different cycles of neoadjuvant chemotherapy combined with immunotherapy in locally advanced esophageal squamous cell carcinoma: a multi-center, real-world study. World J Surg Oncol Lv H, Wang Z, Su C, Wang H, Chen B, Gai C, Liu Y, Ding W, Wang M, Sun K, Zhang F, Zhu Y, Li Z, Tian Z. PMID: 42968170 [PubMed - indexed for MEDLINE]
	NOSES-facilitated transoral en-bloc excision of tongue squamous cell carcinoma via an adapted face-lift method: an initial technical case series. BMC Oral Health Wang WQ, Ahmadi S, Mohammadpour D, Mu SQ, Ding MC, Chen J, Zhang X, Feng F, Na SJ, Wei JH. PMID: 42968089 [PubMed - indexed for MEDLINE]
	Microbiome-derived TOPOSCORE is associated with response to immune checkpoint inhibitor re-induction after chemotherapy in primary resistant metastatic melanoma. Cancer Immunol Immunother Haferkamp S, Schilling B, Baumgart L, Gesierich A, Glutsch V, Drexler K, Wein L, Morak M, Erdmann M, Berking C, Piccinno G, Derosa L, Zitvogel L, Wang Y, Heinzerling L. PMID: 42965706 [PubMed - indexed for MEDLINE]
	Dual-vector nanoengineered mRNA-CRISPR delivery systems for precision gene therapy in choroidal melanoma. Nanomedicine (Lond) Thakur SK, Malviya R, Chandra P, Sridhar SB, Shareef J, Wadhwa T. PMID: 42965688 [PubMed - indexed for MEDLINE]
	Histology-dependent coupling of TERT to the proliferation programme statistically accounts for much of the between-cohort heterogeneity in DNMT3B-TERT co-expression in oesophageal carcinoma: a 27-cohort meta-analysis and pan-cancer re-analysis. Funct Integr Genomics Khorrami M, Parvaresh E, Asadi J, Tatar M. PMID: 42965673 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 145586

Seite 1 von 7280

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung